StockData
GDTCNasdaqPharmaceutical PreparationsFiscal year ends December 31

CytoMed Therapeutics Ltd

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 31, 2026
$0.85−0.03 (-3.17%)

Close on Oct 19, 2026

CytoMed Therapeutics Ltd revenue by segment

No segment breakdown reported

CytoMed Therapeutics does not break out revenue by segment, region or product in the tagged data of its filings for this period type.